COGT · Cogent Biosciences Inc
United States · RS rating 42 · As of 2026-11-03
| Price | 31.06 USD |
|---|---|
| 1-day change | +4.5% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 59 / 24 / 93 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 15 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -10.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +27.5% |
| Market cap (USD) | $5.9B |